Two Sigma Investments
CLRB icon

Two Sigma Investments’s Cellectar Biosciences CLRB Stock Holding History

Two Sigma Investments’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,770
Closed -$26.2K – 3225
2025
Q1 		$26.2K Buy
2,770
+399
+17% +$3.61K ﹤0.01% 3088
2024
Q4 		$21.3K Buy
+2,371
New +$110K ﹤0.01% 3103
2024
Q2 		– Sell
-674
Closed -$80.5K – 3069
2024
Q1 		$80.5K Buy
+674
New +$73K ﹤0.01% 2850
2022
Q1 		– Sell
-217
Closed -$43K – 2936
2021
Q4 		$43K Buy
217
+62
+40% +$14.9K ﹤0.01% 4147
2021
Q3 		$43K Sell
155
-701
-82% -$214K ﹤0.01% 4154
2021
Q2 		$306K Sell
856
-1,355
-61% -$588K ﹤0.01% 3500
2021
Q1 		$1.07M Buy
2,211
+2,054
+1,308% +$1.22M ﹤0.01% 2251
2020
Q4 		$98K Buy
+157
New +$72.2K ﹤0.01% 3214

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Two Sigma Investments's CLRB Position: Q2 2025 in Review

Two Sigma Investments sold out of Cellectar Biosciences (CLRB) in Q2 2025, closing a stake of 2,770 shares — an estimated $26.2K sold.

Two Sigma Investments first reported a position in CLRB in Q4 2020 and held it in 8 quarters. The position peaked at $1.07M in Q1 2021. 19 funds tracked by Wall St. Rank hold CLRB as of Q2 2025.

  • Two Sigma Investments reported no remaining Cellectar Biosciences position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 2,770 Cellectar Biosciences shares in Q2 2025, an estimated $26.2K.
  • Two Sigma Investments first reported a position in Cellectar Biosciences in Q4 2020 and held it in 8 quarters.
  • Two Sigma Investments's Cellectar Biosciences position peaked at $1.07M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.